stockrowXencor, Inc.
XNCR Healthcare Biotechnology
Xencor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $125.6 million, up 13.7% from fiscal 2024.
- Revenue
- +17.5%
- EPS
- +29.3%
- Free cash flow
- −52.9%
Quarter to June 2026, against a year earlier
Follow XNCR
Alert me
Xencor, Inc. (XNCR) Operating margin
Xencor, Inc.'s operating margin over the twelve months to 30 June 2026 was −205.8%, down 64.5 percentage points from fiscal 2025 (−141.4%). Over the past ten years it has ranged from −195.5% (fiscal 2018) to 40.4% (fiscal 2016); the current reading is higher than 27% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −141.4% | 20.12 |
| FY2024 | −161.5% | (85.67) |
| FY2023 | −75.8% | (25.69) |
| FY2022 | −50.1% | (66.02) |
| FY2021 | 15.9% | 78.50 |
| FY2020 | −62.6% | (71.41) |
| FY2019 | 8.82% | 204.30 |
| FY2018 | −195.5% | (102.04) |
| FY2017 | −93.4% | (133.84) |
| FY2016 | 40.4% | 106.45 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | −72.4% | 1,651.77 |
| Mar 2026 | −1,724.1% | (1,534.22) |
| Dec 2025 | −189.9% | 36.37 |
| Sep 2025 | −226.3% | (150.22) |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| ADMA ADMA Biologics Inc compare | 46.5% |
| MBX MBX Biosciences, Inc. compare | 0.00% |
| PHVS Pharvaris N.V. compare | 0.00% |
| ZLAB Zai Lab Limited Unsponsored ADR compare | −63.0% |
| XNCR Xencor, Inc. | −205.8% |
| BEAM Beam Therapeutics Inc. compare | −267.7% |
| RCUS Arcus Biosciences, Inc. compare | −475.0% |
| RXRX Recursion Pharmaceuticals, Inc. compare | −725.4% |
| NAMS NewAmsterdam Pharma Company N.V. compare | −900.1% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on XNCR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement